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Abstract 
The synthesis of the 5-hydroxyproline derivatives 3a and 3b using cyclobutane serine analogs 1 
and 2 as starting materials is reported. This process occurs with moderate cis/trans selectivity. A 
mechanism for this reaction is also proposed. Cyclobutane serine analog 1 was tested in tandem 
Michael and Wittig-like reactions, providing some evidence of the mechanism proposed. 
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Introduction 
 
3-Hydroxyproline and 4-hydroxyproline are basic components of collagen, the most abundant 
protein in vertebrates.1 Both of these proline derivatives are non-proteinogenic amino acids that 
play an important role in the stabilization of the collagen triple helix.2 As far as 5-hydroxyproline 
is concerned, its concentration in injured tissues is a parameter associated with their wound 
healing capacity.3 In addition, 5-hydroxyprolines have been used as building blocks for the 
preparation of other optically active proline derivatives4 and can be considered as versatile 
precursors for the synthesis of conformationally restricted peptidomimetics.5  
Bearing all that in mind, different protocols have been developed to obtain these 5-
hydroxylated compounds. The main methodology consists of the reduction of the γ-lactamic 
carbonyl group of conveniently protected pyroglutamic acid derivatives as a key step of the 
synthesis.5,6 A wide variety of 5-hydroxyprolines have been prepared according to this 
methodology (Scheme 1a). It has also been reported that the N-Boc-protected aldehyde derived 
from glutamic acid is spontaneously transformed into the corresponding 5-hydroxyproline tert-
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butyl ester.7 On this basis, Johannesson et al. achieved the synthesis of the Fmoc-protected 
diastereomeric mixture depicted in Scheme 1b from commercially available Boc-Glu-OtBu.8
Furthermore, α,α-disubstituted 5-hydroxyprolines have been prepared in good enantiomeric 
excess by organocatalytic asymmetric synthesis. It has recently been described that the reaction 
between α,β-unsaturated aldehydes and either 2-acylaminomalonates9 or oxazolones10 leads to 
the type of hydroxyprolines displayed in Scheme 1c in good yields. Finally, as an example of the 
synthesis of 5-alkoxyprolines, the preparation of the 5-methoxyproline presented in Scheme 1d 
was accomplished by a less common strategy, which involves the regioselective electrochemical 
oxidation of the corresponding bicyclic precursor.5c,11 
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Scheme 1 
 
In contrast, cyclobutane compounds have received great attention in the last few years,12 since 
they are important building blocks for the preparation of natural products. Particularly, the 
interest in the synthesis of new cyclobutane amino acids13 has increased after the discovery of 
potent naturally occurring neurotransmitters with the same substructure.14 In this context, our 
research group has reported some examples of these types of substrates.15 In all cases, the four-
member ring formation was based on the formal [2+2] cycloaddition between 
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acylaminoacrylates and different donor olefins. Thus, the reaction between 2-
(acylamino)acrylates and ketene diethyl acetal provides the cyclobutane skeleton following a 
Michael-Dieckmann-type mechanism,12c,15a,b,d,16 whereas the use of monosubstituted donor 
alkenes with the same acrylate acceptors requires activation by aluminium Lewis Acids,15c,e 
leading to the products via stereoselective Michael-aldol processes15c,e (Scheme 2a). It is worth 
mentioning that a number of serine (c4Ser), cysteine (c4Cys), glycine (c4-α-vinylGly) and 
homoalanine (c4homoAla) analogs were obtained by this methodology. Among the c4Ser 
derivatives, compounds 1 and 2 displayed in Scheme 2b have been used as starting materials for 
the work described herein. 
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Scheme 2 
 
In this paper we report the simple preparation of the 5-hydroxyprolines 3 using the serine 
cyclobutane derivatives 1 and 2 as starting materials (Scheme 2b). Moreover, as a possible 
synthetic application, the reactivity of compound 1 was tested in tandem Michael and Wittig-like 
reactions. 
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Results and Discussion 
 
Synthesis of 5-hydroxyproline derivatives 
Cyclobutane alcohol 1 was prepared in good yield by conventional hydrogenolysis of the 
benzyloxy derivative 4 in ethyl acetate using 10% Pd-C as a catalyst (Scheme 3). The synthesis 
of compound 4 had been previously described by our group and involved the formal [2 + 2] 
cycloaddition between methyl 2-acetamidoacrylate and benzyl vinyl ether assisted by MABR as 
Lewis Acid.15c
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Scheme 3 
 
Similarly, as stated above, the diethyl acetal analog 5 had also been synthesized by our group 
by formal [2 + 2] cycloaddition between methyl 2-acetamidoacrylate and ketene diethyl 
acetal.12c,15a,b,d,16 This compound proved to be quite unstable when subjected to a number of test 
reactions, resulting in formation of the glutamic acid derivative 6 by ring opening (Scheme 
4a).15d Bearing that in mind, and given the conformational rigidity of the cyclobutane skeleton, it 
was decided to test the stability and/or reactivity of these types of systems under different 
conditions. Thus, compound 1 was treated with one equivalent of sodium hydride in THF at 
room temperature, leading to a mixture of the 5-hydroxyprolines 3a and 3b in a 68/32 ratio 
(Scheme 4b). Assignment of the signals corresponding to 3a (cis, red in Figure 1) and 3b (trans, 
blue in Figure 1) was carried out by selective 1D ROESY experiments performed over a sample 
purified by silica gel column chromatography, whereas the cis/trans ratio was determined by 
integration of the 1H NMR signals identified for each 5-hydroxyproline.  
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Figure 1. Example of a selective 1D ROESY experiment at a mixing time of 800 ms performed 
over a sample containing a mixture of 3a and 3b. 
 
In order to explore this reaction in more detail and to understand the influence of the reaction 
conditions in the cis/trans (3a/3b) selectivity, compound 1 was subjected to treatment with other 
bases at different temperatures (Table 1). As can be deduced from Table 1, temperature does not 
seem to make any difference in the cis/trans selectivity, since all the results obtained for tBuOK 
are within a 2% range. Nevertheless, more important variations are observed depending on the 
base selected, with the 3a/3b ratio ranging from 68/32 (for NaH) to 45/55 (for Cs2CO3). It is 
important to note that in most cases, the cis derivative is the favored stereoisomer. Only 
treatment with cesium carbonate leads to the trans isomer as the major product. 
 
Table 1. Reaction conditions and cis/trans selectivity obtained in the synthesis of 5-
hydroxyprolines 3a and 3b starting from compound 1 
Base Temperature 3a/3b ratio 
NaHa 25 ºC 68/32 
DIEAa 25 ºC 60/40 
tBuOKb -10 ºC 62/38 
tBuOKb 40 ºC 61/39 
tBuOKb 25 ºC 60/40 
LiOHb 25 ºC 56/44 
DBUb 25 ºC 55/45 
NH4OHb 25 ºC 53/47 
Cs2CO3b 25 ºC 45/55 
AcOH/AcO- Buffer 25 ºC 69/31 
a 1.0 equivalents of base used; 
b 0.1 equivalents of base used; 
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A proposed mechanism for this reaction in basic media is depicted in Scheme 5. First, a 
retroaldolic process takes place after removal of the hydroxyl proton by the corresponding base. 
The aldehyde formation along with the cyclobutane ring opening leads to a tertiary carbanion. 
Secondly, a series of acid-base equilibriums results in an amide anion formation. Finally, the 
amide nucleophilic attack onto the aldehyde carbonyl group gives the 5-hydroxyproline mixture 
3a/3b after protonation. The electron-withdrawing character of the carboxylate group could be 
the driving force of the reaction, since it is capable of stabilizing the carbanion formed in the 
retroaldolic process. 
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Scheme 5 
 
Likewise, ring opening and further 5-hydroxyproline formation was observed when 
compound 1 was treated in acidic conditions (acetic acid/sodium acetate buffer). Remarkably, 
the cis/trans selectivity obtained (69/31, Table 1), was the best of the series. 
An alternative approach to accomplishing the synthesis of the 5-hydroxyprolines 3a and 3b 
might be the in situ generation of the same alkoxy anion displayed in Scheme 5 using a different 
starting material. Consequently, deprotection of alkyl silyloxy derivatives with fluoride anions 
appeared to be a valid possibility. In this context, our group has previously reported the synthesis 
of the trimethylsilyloxy derivative 2 by the usual [2 + 2] cycloaddition methodology.15c This 
compound was selected as the starting material for the reaction with different fluorides in THF 
aiming at the preparation of substrates 3a and 3b. As expected, and as in the case of the 
treatment of compound 1 with different bases, the hydroxyprolines 3a and 3b were the isolated 
products (Scheme 6). The results obtained under the reaction conditions tested are gathered in 
Table 2. 
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Table 2. Cis/trans selectivity obtained in the synthesis of 5-hydroxyprolines 3a and 3b starting 
from compound 2 
Fluoride Source Temperature 3a/3b ratio 
TBAF 0 ºC 59/41 
TBAF 25 ºC 30/70 
HF.Py 25 ºC 55/45 
 
Unlike the case of treatment of compound 1 with different bases, the temperature has an 
important effect on the cis/trans selectivity. Thus, when TBAF is used as the fluoride source at 
0 ºC, the cis isomer is the major product, whereas at 25 ºC, the cis/trans selectivity is in favor of 
the latter one. Similarly, at 25 ºC, the exchange of TBAF by HF.Py provokes a change in the 
3a/3b selectivity. Taking these results into account, the stereochemistry of this process appears 
to be reasonably sensitive to the reaction conditions. 
 
Synthetic applications: Michael and Wittig-like reactions 
Among the four intermediates proposed in the mechanism depicted in Scheme 5, two of them 
contain the aldehyde group (B and C), which makes them suitable for Wittig-like reactions, 
whereas the other ones, depending on their stability, could be good candidates for use in the 
reaction with different electrophiles, since they are oxygenated nucleophiles (A and D). Bearing 
in mind that these intermediates are generated in situ from compound 1, identification and/or 
isolation of the products expected from such intermediates in either Wittig-like reactions or 
Michael-like additions, using compound 1 as starting material, would provide some evidence of 
the mechanism proposed, and would make this cyclobutane containing analog a versatile 
building block for the synthesis of more complex molecules. 
When compound 1 was treated with different Michael acceptors such as acrylonitrile, 
acrolein or methyl acrylate in the presence of tBuOK, only methyl acrylate led to formation of 
products different from the 5-hydroxyprolines 3a and 3b. In this case, although compounds 3a 
and 3b were also the main products, a mixture containing the two diastereomers of the diester 7 
was isolated in a 14% yield (Scheme 7a). As might be expected, these side products were the 
result of the Michael addition of the last intermediate (D) proposed in Scheme 5 to methyl 
acrylate. The low yield obtained could be explained by a fast final protonation step to form the 5-
hydroxyproline derivatives, which would prevent the Michael addition to the α,β-unsaturated 
systems used. 
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Scheme 7 
 
 
Regarding Wittig-like reactions, different phosphorus derivatives can be used in these types 
of processes.17 Among these derivatives, trimethyl phosphonoacetate was selected to carry out 
the reaction with compound 1 in the presence of NaH. Thus, when one equivalent of compound 1 
was reacted with two equivalents of the phosphorus derivative and two equivalents of NaH, the 
expected α,β-unsaturated diester 8 was obtained in a 69% yield (Scheme 7b). Conversely to 
what is described in the literature,18 the Wittig-product 8 did not undergo ring closure by 
intramolecular Michael addition to form the pyrrolidine mixture 9. 
After these preliminary results, it can be said that the use of compound 1 as starting material 
in tandem Michael and Wittig-like reactions has provided some evidence of the mechanism 
proposed in Scheme 5, proving its potential as a building block for the synthesis of more 
complex molecules. 
 
 
Conclusions 
 
In this work a new and simple methodology for the preparation of the 5-hydroxyprolines 3a and 
3b has been developed. This methodology relies on the use of cyclobutane serine analogs 1 and 2 
as starting materials. Treatment of derivative 1 in basic media or fluoride removal of the 
trimethylsilyloxy group present in compound 2 with different fluoride sources led to the 5-
hydroxyprolines 3a and 3b in good yield and moderate selectivity. 
In addition, supporting evidence of the mechanism proposed was provided by the use of 
compound 1 in tandem Michael and Wittig-like reactions. 
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Experimental Section 
 
General Procedures. Solvents were purified according to standard procedures. Analytical TLC 
was performed using Polychrom SI F254 plates. Column chromatography was performed using 
silica gel 60 (230-400 mesh). 1H and 13C NMR spectra were recorded on a Bruker ARX-300 
spectrometer using CDCl3 with TMS as internal reference. Chemical shifts are reported in parts 
per million on the δ scale and coupling constants are given in Hz. Assignment of all separate 
signals in the 1H NMR spectra was made on the basis of coupling constants, ge-COSY, ge-
HSQC and 1D ROESY experiments on a Bruker AVANCE 400 spectrometer. These 
experiments were processed with Mestre Nova software (Mestrelab Research, Spain). Mass 
spectrometry data were obtained with a Bruker MicrOTOF spectrometer using Electrospray-
Ionization (ESI). Microanalyses were carried out in the Department of Chemistry at the 
Universidad de La Rioja on a CE Instruments EA-1110 analyser and are in good agreement with 
the calculated values. 
 
(1R, 2R)- and (1S,2S)-Methyl 1-acetamido-2-hydroxycyclobutanecarboxylate (1). A solution 
of compound 4 (440 mg, 1.59 mmol) in EtOAc (10 mL) was hydrogenated at room temperature 
and atmospheric pressure in the presence of 40 mg of 10% Pd-C. After complete disappearance 
of the starting material, the reaction mixture was filtered through a pad of Celite to remove the 
catalyst and the filter cake was rinsed with 50 mL of EtOAc. The solvent was evaporated in 
vacuo to give a residue that was purified by silica gel column cromathography eluting with 
MeOH/EtOAc (1:9) to afford compound 1 as a colorless oil (282mg, 95%).  1H-NMR (CDCl3): δ 
1.25-1.82 (m, 1H, H4), 2.00 (s, 3H, CH3CO), 2.18-2.31 (m, 2H, 2H3), 2.43-2.47 (m, 1H, H4), 
3.79 (s, 3H, CH3O), 3.97 (br s, 1H, OH), 4.44 (t, 1H, J = 8.8 Hz, H2), 6.80 (br s, 1H, NH). 13C-
NMR (CDCl3): 23.0 (CH3CO), 23.3 (C4), 26.2 (C3), 52.5 (CH3O), 66.2 (C1), 72.5 (C2), 170.7 
(COO), 172.0 (CON); ESI+ (m/z): 210.0 (M+Na)+; Anal. Calcd. for C8H13NO4 (%): C, 51.33; H, 
7.00; N, 7.48. Found: C, 51.22; H, 7.05; N, 7.51. 
 
General procedure for the preparation of methyl 1-acetyl-5-hydroxypyrrolidine-2-
carboxylates 3a and 3b  
Method A. Compound 1 (50 mg, 0.27 mmol) was dissolved in dry THF (5 mL) and treated with 
the corresponding base (1.0 equiv for NaH and DIEA and 0.1 equiv for the rest of bases). After 
appropriate reaction time, the reaction was stopped with 0.1 N HCl (1 mL), diluted with EtOAc 
(10 mL), and washed with H2O (10 mL). The organic phase was dried over anhydrous Na2SO4, 
filtered, and concentrated in vacuo to give the mixture of 5-hydroxyprolines 3a and 3b. (Yield 
ranging from 70 to 85%).  
Method B. Method B. Compound 2 (70 mg, 0.27 mmol) was dissolved in dry THF (5 mL) and 
treated with either TBAF or HF.Py (1.1 equiv). The reaction mixture was stirred for the 
appropriate reaction time, diluted with EtOAc (10 mL), and washed with H2O (5 mL). The 
organic layer was dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The residue 
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obtained was purified by silica gel column chromatography eluting with MeOH/EtOAc (1:9) to 
give a mixture of 3a and 3b. (Yield ranging from 60 to 75%). 1H-NMR (CDCl3): δ 1.88-2.14 (m, 
8H, CH3CO, CH2, CH2, CH2), 2.16-2.30 (m, 4H, CH3CO, CH2), 2.37-2.47 (m, 1H, CH2b), 2.54-
2.64 (m, 1H, CH2a), 3.71 (s, 3H, CH3Ob), 3.77 (s, 3H, CH3Oa), 4.45 (d, 1H, J = 8.8 Hz, CHa), 
4.56 (d, 1H, J = 8.8 Hz, CHb), 5.57 (d, 1H, J = 5.1 Hz, CHb), 5.76 (d, 1H, J = 5.8 Hz, CHa); 13C-
NMR (CDCl3): 21.6, 21.8 (CH3CO), 25.9, 26.7 (CH2), 28.8, 30.3 (CH2), 52.3, 52.8 (CH3O), 58.4, 
60.3 (CH), 82.1, 83.1 (CH), 170.5, 170.6, 172.2, 172.3 (CO); ESI+ (m/z): 188.2 (M+H)+; Anal. 
Calcd. for C8H13NO4 (%): C, 51.33; H, 7.00; N, 7.48. Found: C, 51.30; H, 7.02; N, 7.53. 
Methyl 1-acetyl-5-((2-methoxycarbonyl)ethoxy)pyrrolidine-2-carboxylate (7). Methyl 
acrylate (0.12 mL, 1.35 mmol) was added to a solution of compound 1 (50 mg, 0.27 mmol) in 
dry THF (5 mL). Then, the reaction mixture was treated with tBuOK (27 µl, 1M in THF) and 
stirred for 1 h. Afterwards, 0.1 N HCl (1 mL) was added dropwise. The new mixture was diluted 
with EtOAc (10 mL), and washed with H2O (10 mL). The organic phase was dried over 
anhydrous Na2SO4, filtered, and concentrated in vacuo to give a residue that was purified by 
silica gel column chromatography eluting with MeOH/EtOAc (1:9) to afford compound 7 as a 
mixture of diastereomers (10 mg, 14% yield). 1H-NMR (CDCl3): δ 1.89-1.95 (m, 1H, CH2), 2.01-
2.09 (m, 2H, CH2), 2.16 (s, 3H, CH3), 2.26-2.33 (m, 1H, CH2), 2.59 (t, 2H, J = 6.0 Hz, CH2CO), 
3.66-3.73 (m, 8H, CH3O, CH3O, CH2O), 4.53 (d, 1H, J = 8.9 Hz, CH), 5.18 (d, 1H, J = 4.2 Hz, 
CH); ESI+ (m/z): 274.5 (M+H)+; Anal. Calcd. for C12H19NO6 (%): C, 52.74; H, 7.01; N, 5.13. 
Found: C, 52.85; H, 7.03; N, 5.18. 
(E)-Dimethyl 6-acetamidohept-2-enedioate (8). Trimethyl phosphonoacetate (77 µl, 0.53 
mmol) was added at -30 ºC to a solution of 60% NaH (11 mg, 0.53 mmol) in dry THF (5 mL). 
The reaction mixture was stirred at the same temperature for 45 min and a solution of compound 
1 (50 mg, 0.27 mmol) in dry THF (5 mL) was added dropwise. The new mixture was let reach to 
25 ºC and stirred for 17 h more. Afterwards, a KH2PO4 buffer solution (5 mL) (pH = 7) was 
added and the aqueous layer was washed with EtOAc (3 x 10 mL). The combination of the 
organic phases was dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The 
residue obtained was purified by silica gel column chromatography eluting with hexane/EtOAc 
(1:4) to afford compound 8 as an oil (45 mg, 69% yield).1H-NMR (CDCl3): δ 1.75 (td, 1H, J = 
12.4 Hz, J = 7.3 Hz, CH2), 1.93-2.01 (m, 4H, COCH3, CH2), 2.15-2.23 (m, 2H, CH2), 3.65 (s, 
3H, CH3O), 3.69 (s, 3H, CH3O), 4.58 (dd, 1H, J =13.1 Hz, J = 7.4 Hz, CH), 5.78 (d, 1H, J = 15.5 
Hz, CH=CHCO), 6.14 (d, 1H, J = 7.5 Hz, NH), 6.85 (m, 1H, CH2CH=CH); 13C-NMR (CDCl3): 
23.1 (COCH3), 27.9, 30.9 (CH2, CH2), 51.4, 51.6, 52.5 (CH3O, CH3O, CH), 121.8 (CH=CHCO), 
147.1 (CH2CH=CH), 166.7, 169.9, 172.6 (CO); ESI+ (m/z): 244.4 (M+H)+; Anal. Calcd. for 
C11H17NO5 (%): C, 54.31; H, 7.04; N, 5.76. Found: C, 54.35; H, 7.12; N, 5.79. 
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